NovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova Available in New Zealand

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today announced that the company’s breakthrough prescription daily eyelid and lash hygiene product, Avenova™, will be marketed in New Zealand through a partnership with Ophthalmic Instrument Company. Ophthalmic Instrument Company (OIC) is the leading supplier of diagnostic and